Antinuclear

According to ANSTO Waste Projects & Strategic Planning Manager Kapila Fernando in 2017:
“ANSTO holds about 50 per cent of the radioactive waste in Australia, and 85 per cent of the waste ‘stream’ is directly associated with this nuclear medicine manufacturing program – including the fuel used to power the reactor, the machines used in medicine production, and the gloves and gowns used in the manufacture or administration processes – the cycle to produce radionuclides produces nuclear medical waste.”When questioned by (then) Senator Scott Ludlam (Senate Economics Legislation Committee Session May 2017); ANSTO CEO Adi Paterson informed us that in the 2016 financial year 80% of ANSTO’s diagnostic medical isotope production consisted of Molybdenum 99. Of which only 28% was used in Australia whilst 72% was exported.
.
Let’s do the medical waste maths: – (50% x 85%) = 42.5 % of the national radioactive waste inventory results from medical isotope production. Currently (72% x 80%) = 57.6% of that results from Mo99 exports: which in future will triple, but at 2016 stood at (57.6% x 42.5%) = 24.5% of the total.

Therefore, only 18% (42.5%-24.5%) results from actual national use of medical isotopes: & not all of the 18% requires containment in the proposed facility.

PS ANSTO will not tell us the cost for producing OS exports vs economic return ~ but there is a very high probability (bordering on certainty) that the taxpayer is heavily subsidising OS usage…more  https://www.facebook.com/groups/1314655315214929/